美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

上海医药ADR

7.07

0.0000

成交量：- -

成交额：- -

市值：52.38亿

市盈率：8.77

高：7.07

开：7.07

低：7.07

收：7.07

52周最高：8.32

52周最低：6.39

股本：7.41亿

流通股本：3.65亿

量比：0.11

换手率：- -

股息：0.30

股息率：4.21%

每股收益(TTM):0.8063

每股收益(LYR):0.8419

净资产收益率：7.91%

总资产收益率：2.15%

市净率：0.48

市盈率(LYR):8.40

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

上海市经信委：在上海好模型不缺算力，好应用不缺语料，好产品不缺芯片

上海医药：芪苓颗粒获得临床试验批准通知书

格隆汇资讯

上海医药B023细胞注射液临床试验获批

中信建投：脑机接口有望打开万亿市场空间需发掘国家政策支持和具有真实需求“真脑机”

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SHPMY"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SHPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPMY\",,,,,undefined,":{"symbol":"SHPMY","market":"US","secType":"STK","nameCN":"上海医药ADR","latestPrice":7.07,"timestamp":1771016400000,"preClose":7.07,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":365061763,"shares":740922171,"eps":0.806273,"marketStatus":"总统日休市","change":0,"latestTime":"02-13 16:00:00 EST 延时","open":7.07,"high":7.07,"low":7.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.806273,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":7.07,"volumeRatio":0.10582018980438346},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPMY\",,,,,undefined,":{"symbol":"SHPMY","floatShares":365061763,"roa":"2.15%","roe":"7.91%","lyrEps":0.841928,"volumeRatio":0.10582018980438346,"shares":740922171,"dividePrice":0.297795,"high":7.07,"amplitude":0,"preClose":7.07,"low":7.07,"week52Low":6.39,"pbRate":"0.48","psRate":"0.13","week52High":8.32,"institutionHeld":0,"latestPrice":7.07,"eps":0.806273,"divideRate":0.042121,"volume":0,"delay":15,"ttmEps":0.806273,"open":7.07,"prevYearClose":8.23,"prevWeekClose":7.07,"prevMonthClose":8.23,"prevQuarterClose":8.23,"fiveDayClose":7.97,"twentyDayClose":8.23,"sixtyDayClose":8.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHPMY\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"SHPMY","amount":0.084937,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"上海医药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-23","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-02-23"},{"date":"2025-07-17","symbol":"SHPMY","amount":0.202369,"announcedDate":"2025-06-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-17","defaultRemindTime":1752759000000,"name":"上海医药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-07-17","currency":"USD","dateTimestamp":1752724800000,"payDate":"2025-09-09"},{"market":"US","date":"2025-03-27","symbol":"SHPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"","actualEps":null},{"date":"2024-09-19","symbol":"SHPMY","amount":0.0562,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-19","defaultRemindTime":1726752600000,"name":"上海医药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-12","payableDate":"2024-09-19","currency":"USD","dateTimestamp":1726718400000,"payDate":"2024-11-12"},{"market":"US","date":"2024-08-26","symbol":"SHPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1724644800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHPMY\",market:\"US\",,,undefined,":[{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-09-12","value":0.198416,"currency":"USD"},{"executeDate":"2019-07-11","recordDate":"2019-07-12","paymentDate":"2019-09-09","value":0.237205,"currency":"USD"},{"executeDate":"2020-07-15","recordDate":"2020-07-16","paymentDate":"2020-09-08","value":0.245893,"currency":"USD"},{"executeDate":"2021-07-14","recordDate":"2021-07-15","paymentDate":"2021-09-13","value":0.293406,"currency":"USD"},{"executeDate":"2023-07-17","recordDate":"2023-07-18","paymentDate":"2023-09-12","value":0.421212,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5714,"hold":0.2857,"sell":0.1429,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.2857,"analysts":7,"updateTime":1757653200000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SHPMY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609461095","title":"上海市经信委：在上海好模型不缺算力，好应用不缺语料，好产品不缺芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=2609461095","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609461095?lang=zh_cn&edition=fundamental","pubTime":"2026-02-07 12:48","pubTimestamp":1770439680,"startTime":"0","endTime":"0","summary":"近期上海多家AI企业上市，上海也提出加速人形机器人等创新产品突破产业规模化发展瓶颈。在上海，好模型不缺算力，好应用不缺语料，好产品不缺芯片。上海拥有全国近10%的算力，运营全国首个语料公共服务平台，推出138款备案大模型，实现多款智算芯片突破。《上海市经信委：在上海好模型不缺算力，好应用不缺语料，好产品不缺芯片》栏目主编：张骏文字编辑：曹飞","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-02-07/doc-inhkykzi4217183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SHPMY","BK4588","02607","BK4535","00807","161631","601607","BK4585","159813"],"gpt_icon":0},{"id":"2607707197","title":"上海医药：芪苓颗粒获得临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607707197","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607707197?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 16:20","pubTimestamp":1769674855,"startTime":"0","endTime":"0","summary":"格隆汇1月29日丨上海医药(601607.SH)公布，公司下属正大青春宝药业有限公司（简称“青春宝”）自主研发的“芪苓颗粒”（称“该项目”）收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，芪苓颗粒处方源自杭州市中医院的临床验方。人用经验研究表明本品可缓解患者持续的关节肿痛症状，减少痛风急性发作次数；药效学试验表明本品与降尿酸化学药物联用可增强降尿酸效果，同时具有减轻肾脏病理损伤、保护肾功能的作用。该项目由青春宝自主研发，拥有核心知识产权。截至本公告披露日，该项目已累计投入研发费用约1,142万元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162135a6bace52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162135a6bace52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHPMY"],"gpt_icon":0},{"id":"2605145976","title":"上海医药B023细胞注射液临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145976","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605145976?lang=zh_cn&edition=fundamental","pubTime":"2026-01-20 18:55","pubTimestamp":1768906510,"startTime":"0","endTime":"0","summary":"北京商报讯（记者 王寅浩 宋雨盈）1月20日，上海医药发布公告称，公司下属上海医药集团生物治疗技术有限公司自主研发的“B023细胞注射液”收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意开展不可手术的经标准治疗失败的、无有效治疗方式的局部晚期或转移性实体瘤的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120185825a440bec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120185825a440bec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHPMY"],"gpt_icon":0},{"id":"2601868644","title":"中信建投：脑机接口有望打开万亿市场空间 需发掘国家政策支持和具有真实需求“真脑机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2601868644","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601868644?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 11:27","pubTimestamp":1767670058,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，脑机接口升级为十五五产业战略，多重政策强力支持下，产业落地有望提速，建议重视投资机遇。脑机接口是医疗投资也是科技投资，短期来看主要应用于疾病治疗，长期来看若能实现增强人、并与AI和机器人融合，有望打开万亿市场空间。在投资方向选择方面，非侵入式和侵入式脑机接口无优劣之分，但需发掘国家政策支持和具有真实需求的“真脑机”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106113407a6f87063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106113407a6f87063&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","06160","LU2045819591.USD","BK1583","01099","LU0052750758.USD","LU2125910500.SGD","03347","09926","SHPMY","BK1576","LU0708995583.HKD","02269","BK1161","02359","LU0320764599.SGD","01801","BK1574","06978","LU1046422090.SGD","02607","BK1141","01177","00013"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SHPMY\",params:#limit:6,delay:false,,,undefined,":[]}}